LICN
Lichen International Limited
There isn't enough reported data to score LICN yet.
LICN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Strong |
LICN's balance sheet is currently strong, but its profitability is weak. There isn't enough data to rate its revenue and cash flow.
LICN PE Valuation
LICN has no meaningful PE right now: it lost money over the past year.
LICN Forward outlook
There aren't enough analyst estimates for LICN to show an outlook.
LICN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2025 | -$73.25 | -222% |
| Q4 2024 | -$34.79 | -154% |
LICN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $10.3M | -28% |
| Q4 2025 | $10.3M | -56% |
| Q2 2025 | $14.3M | -21% |
| Q4 2024 | $23.4M | -1.9% |
| Q2 2024 | $18.1M | +14% |
| Q4 2023 | $23.8M | +35% |
| Q2 2023 | $15.9M | -1.4% |
| Q4 2022 | $17.7M | +2% |
LICN's revenue has slid since its 2023 peak: $10M last quarter, down 43% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -85% | -94 points |
| Q4 2025 | -89% | -129 points |
| Q2 2025 | -37% | -55 points |
| Q4 2024 | -27% | -54 points |
| Q2 2024 | 9.4% | -26 points |
| Q4 2023 | 39% | +13 points |
| Q2 2023 | 18% | -21 points |
| Q4 2022 | 28% | -2.8 points |
LICN's operating margin was −85% last quarter, down 94 points from the same quarter a year ago, near the bottom of its range since 2014.
LICN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2023 | -$1.7M | -146% |
| Q2 2023 | -$956K | -119% |
| Q4 2022 | $3.7M | -1.4% |
| Q2 2022 | $5.2M | +45% |
| Q4 2021 | $3.7M | -31% |
| Q2 2021 | $3.6M | +21% |
| Q4 2020 | $5.4M | +295% |
| Q2 2020 | $2.9M | +114% |
LICN's free cash flow has turned negative after years in the green: −$19M over the past year.
LICN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +10881% | +16.2M shares |
| 3 years | -27% | -6.2M shares |
| 5 years | -43% | -12.4M shares |
LICN has 16M diluted shares, up 10881% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q4 2025 | — |
| Q4 2022 | — |
| Q2 2022 | — |
| Q4 2021 | — |
| Q2 2021 | — |
| Q4 2020 | — |
| Q2 2020 | — |
LICN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -1.6x | Net Cash |
LICN has more cash than debt.
LICN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.7 | Neutral |
| Stochastic | 1.5 | Oversold |
LICN's weekly RSI is 34 (neutral) and its Stochastic is 2 (oversold).
LICN PE vs Industrials Sector
| Metric | LICN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
LICN has no meaningful PE right now: it lost money over the past year.
LICN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.75 | 95% below |
| 20 week MA | $1.03 | 96% below |
| 50 week MA | $2.48 | 98% below |
| 100 week MA | $5.66 | 99% below |
LICN is in a downtrend: it's below all four of its weekly moving averages, and 99% below its 100-week average.
LICN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $820.0 | $396.0 | -52% |
| 2024 | $396.0 | $46.4 | -88% |
| 2025 | $46.4 | $2.97 | -94% |
| 2026 YTD | $2.97 | $0.04 | -99% |
LICN has finished every year since 2023 lower, and it's down 99% so far in 2026.